SGP compared with ACRV: revenue, margins and what each company keeps, and the suppliers and customers both name

SGPSpyGlass Pharma, Inc.

Mkt capRevenueRevenue

ACRVAcrivon Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SGPSpyGlass Pharma, Inc.

ACRVAcrivon Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

SGPSpyGlass Pharma, Inc.

32.14▼−1.14%· post 32.36

Mkt cap$1.1B

ACRVAcrivon Therapeutics, Inc.

1.67▼−5.40%· post 1.67

ClosedOct 30 '26

Mkt cap$12.5M

Compare

ClosedOct 30 '26

SGPSpyGlass Pharma, Inc.

ACRVAcrivon Therapeutics, Inc.

32.14▼−1.14%post 32.36

Price

1.67▼−5.40%post 1.67

$1.1B

Mkt cap

$12.5M

SGP32.14▼−1.14%vsACRV1.67▼−5.40%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

SGP, solidACRV, dashed

Supply-chain overlap

Revenue flow

SGP: latest quarter not drawable. ACRV: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SGP 1

—Regents of the University of Colorado (CU)unlistedsupplier

Shared 0

No shared counterparties.

Only ACRV 7

LLYEli Lilly & Company (Lilly)supplier

—Akoyaunlistedsupplier

—MD Anderson Cancer Center (MDACC)unlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Moffitt Cancer Center

unlistedsupplier

3 more · ACRV chain ›